Evidence map›Paper›PMID 42902865›Full record

ArticleAging cell2026

The Senokine Gas6 Promotes Aortic Valve Calcification Through CaMKII-DRP1-Mediated Terminal Scission of Mitochondrial-Derived Vesicles.

Yaoyu Zhang, Jialiang Zhang, Yanjiani Xu, Wenhua Lei, Fei Xu, Junli Li, Zisong Wei, Bo Su, Shuang Liu, Jing Zhou and 8 more

Abstract read
In one paragraph

Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yaoyu ZhangLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID https://orcid.org/0009-0001-3263-3617
Jialiang ZhangLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID https://orcid.org/0000-0001-7737-0323
Yanjiani XuLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID https://orcid.org/0000-0002-7765-514X
Wenhua LeiLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID https://orcid.org/0000-0002-5324-3503
Fei XuLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Junli LiLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Zisong WeiLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID https://orcid.org/0009-0004-4710-5333
Bo SuCore Facilities of West China Hospital, Chengdu, Sichuan, China.
Shuang LiuLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Jing ZhouLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Hongde LiLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID https://orcid.org/0009-0008-0701-2393
Junpeng RanLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID https://orcid.org/0009-0003-1381-6797
Weiya LiLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Tuerhongjiang TuerdiLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID https://orcid.org/0009-0000-7101-351X
Xiaojiao WangCore Facilities of West China Hospital, Chengdu, Sichuan, China.ORCID https://orcid.org/0000-0002-7091-9923
Zhi FangDepartment of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID https://orcid.org/0000-0002-0724-8485
Fangyang HuangLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID https://orcid.org/0000-0002-3049-2996
Mao ChenLaboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID https://orcid.org/0000-0002-7352-0563

Funding

Fundamental Research Funds for the Central UniversitiesNational Natural Science Foundation of China 82170375National Natural Science Foundation of China 82500455National Natural Science Foundation of China U23A20395Natural Science Foundation of Sichuan Province 2026NSFSC0552Noncommunicable Chronic Diseases-National Science and Technology Major Project 2026ZD0554300
6 · The paper itself

Abstract

Calcific aortic valve disease (CAVD) is an age-associated valvular disorder in which calcification expands from discrete foci into adjacent tissue. We investigated whether mitochondrial-derived vesicles (MDVs) released by human valvular interstitial cells (hVICs) exert pro-calcific effects on recipient cells and how MDV release is regulated. Using ex vivo hemodynamic perfusion of human CAVD tissue, multi-omics profiling, live-cell single-organelle tracking, MDV transfer assays, and in vivo Gas6 deletion, we found that calcifying hVICs hypersecreted MDVs that exerted pro-calcific effects in recipient hVICs. High-resolution imaging showed that mitochondria remodeled into donut-shaped structures under pro-osteogenic conditions; these structures served as physical platforms for MDV budding. Human CAVD valve tissues and hVICs treated with pro-osteogenic medium also exhibited senescence-associated features. Multi-omics profiling identified growth arrest-specific 6 (Gas6), a senokine, among 36 concordantly upregulated candidates. Functional analyzes showed that Gas6 promoted terminal MDV scission while leaving donut-shaped mitochondrial precursor formation intact. Mechanistically, Gas6 promoted intracellular Ca

Indexed as

Aortic ValveAortic Valve StenosisCalcinosisCalcium-Calmodulin-Dependent Protein Kinase Type 2DynaminsIntercellular Signaling Peptides and ProteinsMitochondriaAnimalsGrowth Arrest-Specific Protein 6HumansCalcium-Calmodulin-Dependent Protein Kinase Type 2DynaminsGrowth Arrest-Specific Protein 6Intercellular Signaling Peptides and Proteinsaortic valve calcificationcalcific aortic valve diseaseGas6mitochondrial‐derived vesicles

Identifiers

PMID42902865
PMCPMC13684317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.